Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

293-Day Intra-Aortic Balloon Pump Support as a Bridge to Transplantation in Refractory Heart Failure.

Created on 09 Nov 2026

Authors

Alexia B Bernardes, Humberto Benedetti, Renata L Hames, Victor G Galoro, Jairo A Pinheiro Junior, Frederico C C Mendonça, Stevan K Martins

Published in

JACC. Case reports. Pages 111134. Nov 09, 2026. Epub Nov 09, 2026.

Abstract

The intra-aortic balloon pump (IABP) is widely used as temporary mechanical circulatory support in patients with refractory heart failure complicated by cardiogenic shock. However, its use is generally limited to short-term therapy because of device-related complications.
A 57-year-old man with idiopathic dilated cardiomyopathy receiving guideline-directed medical therapy and cardiac resynchronization therapy with defibrillation developed cardiogenic shock refractory to inotropic therapy, requiring IABP implantation. Mechanical circulatory support was maintained for 293 days, including 291 days as a bridge to heart transplantation and 2 days after transplantation.
This case demonstrates that prolonged IABP support is feasible when combined with transition to a left subclavian approach, serial device replacement, and meticulous multidisciplinary management.
In carefully selected patients, prolonged IABP support, combined with individualized device management and multidisciplinary care, may provide sustained clinical stabilization and serve as an effective bridge to heart transplantation.

PMID:
43002145
Bibliographic data and abstract were imported from PubMed on 09 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 24
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement